Cardinal Health, Inc.
Location
Ohio
Founded
1979-02-28
Website
Risk Signals
3282 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medical, Dental, and Hospital Equipment and Supplies, Drugs, Drug Proprietaries, and Druggists' Sundries, Management Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Cardinal Health, Inc.
Live alerts from global media, monitored by Business Radar
2025-05-02 (devdiscourse.com)
Global Health Landscape: From Vaccine Innovation to Regulatory Battles | Science-Environment
Recent health news spotlights include Cardinal Health's robust growth forecast despite tariffs, CVS's strategy shifts, Biogen's resilience in rare disease markets, and novel treatments advancements by J&J. Additionally, regulatory and funding challenges faced by WHO and the U.S. emphasize the complex dynamics shaping global healthcare.
Read more
2025-04-16 (theretirementgroup.com)
Cardinal Health Trust as Beneficiary of Traditional IRA or Retirement Plan
Explore how Cardinal Health employees can leverage trusts as beneficiaries for their IRA or Cardinal Health-sponsored retirement plans to secure post-death distributions and tax benefits. Understand the specific requirements and advantages for Cardinal Health workers to make informed estate planning decisions.
Read more
2025-04-09 (modernhealthcare.com)
Specialty Pharmacy Strategies to Reduce Costs and Improve Patient Outcomes in Health Systems |
Cardinal Health's Mike Brown, vice president of managed services, and Naveen Mansukhani, director of specialty and ambulatory pharmacy solutions, join the podcast to explore how health systems can build successful specialty pharmacy strategies that enhance care and drive growth.
Read more
2025-04-04 (globalgrowthinsights.com)
Diagnostic Nuclear Drug Market Size, Share, Growth, and Industry Analysis, By Types (Tc-99m, F-18, Other), By Applications Covered (Oncology, Cardiology, Other), Regional Insights and Forecast to 2033
Global Diagnostic Nuclear Drug Market Size Is Forecasted To Reach USD 5768.5 Billion By 2033 From USD 9837.5 Billion In 2025, Growing At A Steady CAGR of 6.9%
Read more